Nanotechnology drug delivery shows promise for treatment of pediatric cancer
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for na ...
Cancer
Dec 04, 2012 |
not rated yet |
0
New target for treating diabetic kidney disease, the leading cause of kidney failure
Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure. The findings, appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) ...
Diseases, Conditions, Syndromes
Oct 18, 2012 |
5 / 5 (1) |
0
Novel chewing gum formulation helps prevent motion sickness
A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild ...
Medications
Oct 17, 2012 |
not rated yet |
0
Study finds vegetable-derived compound effective in treating triple-negative breast cancer
A new compound created from a rich source in vegetables including broccoli and brussel sprouts has been developed to combat triple-negative breast cancer (TNBC). This research is being presented at the 2012 American Association ...
Cancer
Oct 17, 2012 |
5 / 5 (2) |
0
MRI images transplanted islet cells with help of positively charged nanoparticles
In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged ...
Medical research
Oct 01, 2012 |
not rated yet |
0
An old drug finds a new use
Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...
Medications
Sep 27, 2012 |
not rated yet |
0
Scientists bid to develop anthrax vaccine to counteract world bioterrorism threat
A team of Cardiff University scientists is leading new research to develop a vaccine against anthrax to help counteract the threat of bioterrorism.
Medical research
Sep 17, 2012 |
5 / 5 (1) |
0
'Super tree' maps 20,000 medicinal, related plants
(Medical Xpress)—New research from the University of Reading, The Royal Botanic Gardens, Kew and Imperial College London published on 10 September in the Proceedings of the National Academy of Sciences (PNAS) ...
Medications
Sep 11, 2012 |
5 / 5 (6) |
0
|
Preschool within lymphatic vessels
Not only infants crawl. ETH researchers have shown that so-called dendritic cells, important cells of the immune system, use a similar mode of movement more often than previously assumed. The scientists us ...
Medical research
Aug 09, 2012 |
not rated yet |
0
Sea anemones venom key to Multiple Sclerosis treatment
(Medical Xpress) -- Sea anemones use venomous stinging tentacles to stun their prey, but one component of that venom is being used by researchers to treat the debilitating effects of Multiple Sclerosis (MS).
Immunology
Jul 23, 2012 |
not rated yet |
0
|
3-D tumor models improve drug discovery success rate
Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Op ...
Medications
Jul 20, 2012 |
not rated yet |
0
|
Hulk smash? Maybe not anymore: scientists block excess aggression in mice
Pathological rage can be blocked in mice, researchers have found, suggesting potential new treatments for severe aggression, a widespread trait characterized by sudden violence, explosive outbursts and hostile overreactions ...
Neuroscience
Jun 19, 2012 |
3.8 / 5 (6) |
2
|
Smilagenin represents a new approach for treating neurodegeneration disease
Erxi Wu, assistant professor of pharmaceutical sciences, and Shuang Zhou, a doctoral student in Wu’s lab, co-wrote the article, "Smilagenin Attenuates Beta Amyloid (25-35)-Induced Degeneration of Neuronal Cells via Stimulating ...
Neuroscience
May 07, 2012 |
not rated yet |
0
New drug target improves memory in mouse model of Alzheimer's disease
(Medical Xpress) -- Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the ...
Alzheimer's disease & dementia
Mar 07, 2012 |
5 / 5 (1) |
0
|
NDSU assistant professor publishes paper on pancreatic tumor regulator
Erxi Wu, assistant professor of pharmaceutical sciences, co-wrote the review article, “The paracrine Sonic Hedgehog signaling derived from tumor epithelial cells: A key regulator in the pancreatic tumor microenvironment,” ...
Cancer
Feb 17, 2012 |
not rated yet |
0
